Skip to content
HowShorted

IGM Biosciences, Inc. short interest in 2024

In 2024, IGM Biosciences, Inc.'s disclosed short interest ran from 8.38% of shares outstanding on 12 Jan 2024 to 9.89% on 31 Dec 2024, a change of +1.51 percentage points. The year's high was 22.78% on 15 Aug 2024 and its low 7.72% on 29 Feb 2024, averaging 14.43% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.19 days on 30 Aug 2024. Full history: IGM Biosciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for IGM Biosciences, Inc. in 2024

2024 in figures

Start of year
8.38% (12 Jan 2024)
End of year
9.89% (31 Dec 2024)
Change
+1.51 pp
High
22.78% (15 Aug 2024)
Low
7.72% (29 Feb 2024)
Average
14.43%
Highest days to cover
36.19 (30 Aug 2024)
SEC filings marked
9

Every report in 2024

IGM Biosciences, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20248.38%13.61results (8-K)
31 Jan 20248.03%19.66
15 Feb 20247.83%12.46
29 Feb 20247.72%18.47
15 Mar 20248.09%17.2410-K filed, results (8-K)
28 Mar 20248.88%20.91
15 Apr 20248.92%28.54
30 Apr 202410.61%16.37
15 May 202420.81%23.5710-Q filed, results (8-K)
31 May 202420.25%10.52
14 Jun 202420.39%14.39
28 Jun 202420.55%16.56
15 Jul 202422.45%20.12
31 Jul 202422.20%12.88
15 Aug 202422.78%26.0410-Q filed, results (8-K)
30 Aug 202421.81%36.19
13 Sep 202420.80%32.59
30 Sep 202415.85%6.67
15 Oct 202414.51%10.80
31 Oct 202413.26%18.43
15 Nov 202411.20%9.6210-Q filed, results (8-K)
29 Nov 202410.65%12.00
13 Dec 202410.39%13.50
31 Dec 20249.89%9.44

See also: IGM Biosciences, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.